AC
AC Immune S.A.
ACIU · NASDAQ
$2.76 -1.43% (-$0.04)
1M +8.66%
Market Cap CHF 227.5M
P/E Ratio -
Div. Yield -
ROE 99.17%
Bulios Fair Price
$3.91
41.7% upside
Trenutna cena
$2.76
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ACIU trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
10 /100
Expensive P/S 12.99x
P/B 6.47x
P/E N/A
Growth
3 /100
Declining Rev. growth 3.17%
Book val. growth 35.70%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 100.00%
Net margin 246.49%
Op. margin 252.25%
Quality
2 /100
Poor ROIC 86.61%
ROE 99.17%
ROA 28.70%
Debt
54 /100
Moderate Debt/Equity 0.12x
Current ratio 0.93x
Int. coverage -256.38x
Stability
25 /100
Unstable Beta 1.57x
Rev. volatility 181.62%
EPS volatility 34.57%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ACIU
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Martin Zügel
Employees
106
Headquarters
Lausanne
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report